echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tengshengbo Pharmaceutical Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

    Tengshengbo Pharmaceutical Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

    • Last Update: 2021-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Durham, North Carolina, USA and Beijing, September 28, 2021/PRNewswire/ - Brii Bioscience (stock code: 2137.


    "As we rapidly advance the registration application of the BRII-196/BRII-198 combination therapy for the treatment of COVID-19 in the United States, in preparation for our next stage of development, Coy will become an indispensable part of our leadership team.


    Prior to joining Tengsheng Biopharmaceuticals, Mr.


    "Tengshengbo Pharmaceutical is in an exciting period of development.


    For more information about Briibio and its leadership team, please visit the official website


    About Tengshengbo Pharmaceutical

    Tengsheng Bo Yao Biotechnology Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.